Cite
Leinonen HM, Lipponen EM, Valkama AJ, et al. Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells. Mol Ther Methods Clin Dev. 2019;15:63-71doi: 10.1016/j.omtm.2019.08.006.
Leinonen, H. M., Lipponen, E. M., Valkama, A. J., Hynynen, H., Oruetxebarria, I., Turkki, V., Olsson, V., Kurkipuro, J., Samaranayake, H., Määttä, A. M., Parker, N. R., Ylä-Herttuala, S., & Lesch, H. P. (2019). Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells. Molecular therapy. Methods & clinical development, 1563-71. https://doi.org/10.1016/j.omtm.2019.08.006
Leinonen, Hanna M, et al. "Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells." Molecular therapy. Methods & clinical development vol. 15 (2019): 63-71. doi: https://doi.org/10.1016/j.omtm.2019.08.006
Leinonen HM, Lipponen EM, Valkama AJ, Hynynen H, Oruetxebarria I, Turkki V, Olsson V, Kurkipuro J, Samaranayake H, Määttä AM, Parker NR, Ylä-Herttuala S, Lesch HP. Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells. Mol Ther Methods Clin Dev. 2019 Aug 29;15:63-71. doi: 10.1016/j.omtm.2019.08.006. eCollection 2019 Dec 13. PMID: 31649956; PMCID: PMC6804948.
Copy
Download .nbib